Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy

NCT01301391 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
30
Enrollment
INDUSTRY
Sponsor class

Stopped For the last patient still on treated nominal therapeutic use of the Milciclib was approved at INT Milano.

Conditions

Interventions

Sponsor

Tiziana Life Sciences LTD